10-carboxymethyl-9-acridanone

RN given refers to parent cpd

Also Known As:

10(9H)-acridineacetic acid, 9-oxo-; 10-carboxymethyl-9-acridanone, sodium salt; 9-oxo-10-acridineacetic acid; acridone N-methyl-N-(alpha,D-glucopyranosyl)ammonium 10-methylenecarboxylate; cridanimod; cridanimod sodium; cycloferon; meglumine acridone acetate

Networked: 128 relevant articles (40 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Acridines: 325
      - 10-carboxymethyl-9-acridanone: 128

Experts

1.	Romantsov, M G: 31 articles (01/2014 - 11/2004)
2.	Kovalenko, A L: 28 articles (01/2017 - 01/2000)
3.	Shul'diakov, A A: 17 articles (01/2014 - 01/2009)
4.	Sologub, T V: 10 articles (01/2012 - 01/2009)
5.	Sukhanov, D S: 9 articles (01/2014 - 11/2009)
6.	Ershov, F I: 8 articles (01/2014 - 01/2000)
7.	Frolov, V M: 7 articles (03/2013 - 01/2011)
8.	Soboleva, L A: 6 articles (01/2015 - 01/2010)
9.	Kruglova, O V: 5 articles (03/2013 - 01/2012)
10.	Isakov, V A: 4 articles (01/2015 - 01/2009)

Related Diseases

1.	Infections 09/01/2018 - "[CLINICAL EFFICIENCY OF CYCLOFERON IN CHILDREN AND ADULTS WITH HIV AND/ OR HERPES INFECTION: SYSTEMATIC REVIEW AND META-ANALYSIS]." 01/01/2012 - "The administration of cycloferon significantly increases the absorptive and digestive activity of phagocytosis by peritoneal macrophages, which has been inhibited during the development of experimental MBT infection." 01/01/2011 - "The efficacy and safety of cycloferon in the combined treatment of patients with recurring anogenital herptic infection were estimated. " 01/01/2010 - "The results of the use of cycloferon in the treatment of gastrointestinal tract and intestinal infections of both the viral and bacterial genesis are discussed. " 07/01/2003 - "In generalized herpes infection in non-inbred white mice with undamaged immune status cycloferon increased survival rate by 30-100% in comparison with the controls (untreated mice), while in case of immunosuppression the protective effect of this preparation was considerably lower. "
2.	Brucellosis (Malta Fever) 01/01/2010 - "[Efficacy of cycloferon in the treatment of brucellosis]." 09/01/2012 - "[Effectiveness of cycloferon in complex treatment of brucellosis patients with lesions of the scrotum]." 01/01/2010 - "[Cycloferon in complex therapy of chronic brucellosis]." 01/01/2015 - "To evaluate the efficacy of cycloferon used in the combination treatment of scrotal inflammatory diseases (SID) in patients with brucellosis. " 01/01/2010 - "80 patients with chronic hepatitis and brucellosis were examined in order to determine the efficacy of cycloferon liniment in parodontitis treatment. "
3.	Human Influenza (Influenza) 09/01/2000 - "Protective effect of granulated cycloferon has been studied in albino mice infected with influenza. " 09/01/2000 - "[Protective effect of cycloferon in experimental influenza]." 01/01/2012 - "The epidemiologic efficacy of cycloferon, as an agent of nonspecific immunoprophylaxis for FIC during seasonal prevalence of respiratory tract infection and influenza cases was shown." 12/03/2019 - "Meglumine acridone acetate (MA) is used in Russia for the treatment of influenza and other acute respiratory viral infections. " 01/01/2015 - "[THE USE OF CYCLOFERON FOR THE TREATMENT AND PREVENTION OF INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS]."
4.	Pulmonary Tuberculosis 01/01/2015 - "Thus, the use of Cycloferon in the schemes of the treatment of the patients with fibrocavernous pulmonary tuberculosis allowed to shorten the period of the pathogen carriage (as well as the drug resistant forms) in 94.1 ± 3.33% of the patients in spite of concomitant diseases. " 01/01/2010 - "[Use of cycloferon in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations]." 01/01/2016 - "The pulmonary tuberculosis process as dependent on the disease form and the therapy efficacy with the use of Cycloferon in the treatment scheme were investigated. " 01/01/2013 - "[Effectiveness of immunomodulating therapy of pulmonary tuberculosis with cycloferon]." 01/01/2012 - "A total of 238 patients, including 32 patients with limited forms of the pulmonary tuberculosis and 206 patients had widespread forms of pulmonary tuberculosis, were randomized into the basic group (BG) and comparison group (CG), where 95 CG patients received only polychemotherapy and 111 BG patients received polychemotherapy with the use of cycloferon. "
5.	Chronic Hepatitis B 01/01/2010 - "[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]." 11/01/2010 - "Therapy of chronic hepatitis B with cycloferon can reduce the frequency and severity of side effects, prevents the development of resistance to lamivudin and the emergence of mutant viruses." 06/01/2013 - "323 patients with chronic hepatitis B (HBV) with "wild" HBeAg(+) strain of HBV were treated with cycloferon and Lamivudin for 48 weeks. " 01/01/2013 - "There was observed a positive impact of the cycloferon therapy on the late aftereffects hepatitis C, evidemt from higher frequency of the remissions in the patients with chronic hepatitis B and less frequent transformation of the acute form to the chronic one. " 01/01/2010 - "The use of cycloferon in the therapy of chronic hepatitis B made it possible to lower the frequency and manifestation level of the side effects and prevented the lamivudine resistance development and generation of the virus mutants."

Related Drugs and Biologics

1.	Interferons
2.	Tablets
3.	Antiviral Agents (Antivirals)
4.	Solutions
5.	Ribavirin (Virazole)
6.	Cytokines
7.	Aerosols
8.	10-carboxymethyl-9-acridanone
9.	Immunologic Factors (Immunomodulators)
10.	Acyclovir (Aciclovir)

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)
3.	Injections
4.	Immunotherapy
5.	Transplantation